Does Rallies show 13F holders for EQ?

Yes. Rallies tracks hedge fund and 13F ownership data for EQ, including fund names, share counts, latest tracked quarter, and position changes when available.

Is EQ research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EQ. It does not provide personalized investment advice.

EQ (Equillium, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Equillium, Inc. Common Stock (EQ) is a publicly traded Healthcare sector company. As of May 21, 2026, EQ trades at $2.13 with a market cap of $116.34M and a P/E ratio of -5.01. EQ moved +16.71% today. Year to date, EQ is +31.21%; over the trailing twelve months it is +434.65%. Its 52-week range spans $0.27 to $2.70. Analyst consensus is strong buy with an average price target of $7.67. Rallies surfaces EQ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns EQ stock?

Hedge funds tracked by Rallies that own EQ include Renaissance Technologies, Two Sigma, and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Equillium, Inc. Common Stock.

EQ Key Metrics

Key financial metrics for EQ
Metric	Value
Price	$2.13
Market Cap	$116.34M
P/E Ratio	-5.01
EPS	$-0.39
Dividend Yield	0.69%
52-Week High	$2.70
52-Week Low	$0.27
Volume	295.94K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-22.40M
Gross Margin	0.00%

Top Hedge Funds Holding EQ

Renaissance Technologies holds 261.40K shares of EQ, changed -18.61% as of Dec 31, 2024.
Two Sigma holds 13.54K shares of EQ, changed -22.61% as of Dec 31, 2024.
Citadel Advisors holds 306 shares of EQ, changed -99.51% as of Mar 31, 2024.

Latest EQ News

Equillium to Host May 27 Webinar Revealing AhR Modulator and miR-124 Findings — May 20, 2026
Equillium Raises $35M, Names New CDO, EQ504 Phase 1 Trial Starts Mid-2026 — May 13, 2026
Equillium to Present EQ504 IL-10/IL-22 and Barrier Restoration Data at IMMUNOLOGY2026 — Apr 8, 2026
Equillium posts $22.4M 2025 net loss, secures $35M financing for EQ504 trial — Mar 25, 2026
Equillium Raises $35 Million via 18.9 Million Shares at $1.854 in PIPE Deal — Mar 13, 2026

Recent EQ Insider Trades

Zedelmayer Christine sold 120.31K (~$300.82K) on Mar 13, 2026.
Zedelmayer Christine sold 181.22K (~$362.44K) on Mar 9, 2026.
Zedelmayer Christine sold 109.38K (~$194.84K) on Feb 19, 2026.

EQ Analyst Consensus

6 analysts cover EQ: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.67.

Common questions about EQ

Who owns EQ stock?: Hedge funds tracked by Rallies that own EQ include Renaissance Technologies, Two Sigma, and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Equillium, Inc. Common Stock.
Does Rallies show 13F holders for EQ?: Yes. Rallies tracks hedge fund and 13F ownership data for EQ, including fund names, share counts, latest tracked quarter, and position changes when available.
Is EQ research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EQ. It does not provide personalized investment advice.